In Vitro Responses of Acinetobacter baumannii to Two- and Three-Drug Combinations following Exposure to Colistin and Doripenem
Open Access
- 1 February 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (2) , 1195-1199
Abstract
We compared in vitro killing of colistin, doripenem, and sulbactam by time-kill methods against Acinetobacter baumannii isolates collected from patients before and after colistin-doripenem treatment (initial and recurrent isolates, respectively). Colistin-doripenem bactericidal activity against recurrent isolates was attenuated (mean log 10 kill, −5.74 versus −2.88; P = 0.01) but was restored by adding sulbactam. Doripenem MICs rather than colistin MICs correlated with the activity of colistin-doripenem. Among colistin-resistant isolates, colistin-doripenem-sulbactam combinations achieved greater killing than colistin-doripenem alone (−5.65 versus −2.43; P = 0.04).Keywords
This publication has 13 references indexed in Scilit:
- Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant RecipientsPLOS ONE, 2012
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of PatientsAntimicrobial Agents and Chemotherapy, 2011
- High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimenDiagnostic Microbiology and Infectious Disease, 2011
- Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in PennsylvaniaAntimicrobial Agents and Chemotherapy, 2008
- In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumanniiJournal of Antimicrobial Chemotherapy, 2007
- Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosaClinical Infectious Diseases, 2006
- In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumanniiDiagnostic Microbiology and Infectious Disease, 2005
- Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumanniiClinical Microbiology and Infection, 2004
- Bactec 9240 blood culture system: to preincubate at 35 °C or not?Clinical Microbiology and Infection, 2004
- Sulbactam: Biochemical Factors Involved in Its Synergy with AmpicillinClinical Infectious Diseases, 1986